Skip to main content
Top

Clinical and Translational Oncology

Issue 7/2016

Content (14 Articles)

Review Article

Long noncoding RNAs in lung cancer: what we know in 2015

Y. J. Xu, Y. Du, Y. Fan

Research Article

Further evidence for preoperative chemoradiotherapy and transanal endoscopic surgery (TEM) in T2-3s,N0,M0 rectal cancer

C. Pericay, X. Serra-Aracil, J. Ocaña-Rojas, L. Mora-López, E. Dotor, A. Casalots, A. Pisa, E. Saigí

Research Article

Compliance to radiation therapy of head and neck cancer patients and impact on treatment outcome

B. C. Ferreira, P. Sá-Couto, M. C. Lopes, L. Khouri

Research Article

Can tumor regression grade influence survival outcome in ypT3 rectal cancer?

L. Shen, L. Wang, G. Li, H. Zhang, L. Liang, M. Fan, Y. Wu, W. Deng, W. Sheng, J. Zhu, Z. Zhang

Research Article

CCR6 overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer

X. G. Zhang, B. T. Song, F. J. Liu, D. Sun, K. X. Wang, H. Qu

Research Article

Landscape of early clinical trials for childhood and adolescence cancer in Spain

F. Bautista, S. Gallego, A. Cañete, J. Mora, C. Diaz de Heredia, O. Cruz, J. M. Fernández, S. Rives, L. Madero, V. Castel, M. E. Cela, G. Ramírez, C. Sábado, T. Acha, I. Astigarraga, A. Sastre, A. Muñoz, M. Guibelalde, L. Moreno

Research Article

Clinical significance of cellular and acellular mucin pools in rectal carcinoma following preoperative chemoradiotherapy

J. A. Cienfuegos, J. Baixauli, F. Rotellar, J. Arredondo, J. J. Sola, L. Arbea, C. Pastor, J. L. Hernández-Lizoáin

Research Article

Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients

P. Yadav, M. Masroor, K. Tanwer, R. Mir, J. Javid, I. Ahmad, M. Zuberi, R. C. M. Kaza, S. K. Jain, N. Khurana, P. C. Ray, A. Saxena

Brief Research Article

Stereotactic body radiation therapy (SBRT) delays the emergence of castration resistance in patients with oligometastatic prostate cancer

M. I. Martínez-Fernández, J. L. Pérez Gracia, I. Gil-Bazo, R. Martínez-Monge

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine